Los Angeles Capital Management’s Indivior Pharmaceuticals INDV Stock Holding History
Bought
Maintained
Sold
Other funds holding INDV
OCM
TSC
Los Angeles Capital Management's INDV Position: Q2 2026 in Review
Los Angeles Capital Management reduced its Indivior Pharmaceuticals (INDV) stake by 86% in Q2 2026, selling an estimated $2.55M and leaving 11,837 shares worth $486K. The position accounts for ﹤0.01% of the portfolio, ranked #919.
Los Angeles Capital Management first reported a position in INDV in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.5M in Q1 2026. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.
- Los Angeles Capital Management held 11,837 shares of Indivior Pharmaceuticals worth $486K as of Q2 2026.
- Los Angeles Capital Management sold 70,332 Indivior Pharmaceuticals shares in Q2 2026, an estimated $2.55M.
- Indivior Pharmaceuticals made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #919 holding.
- Los Angeles Capital Management first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
- Los Angeles Capital Management's Indivior Pharmaceuticals position peaked at $2.5M in Q1 2026.
- 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.
Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.